Overview

'ADVANCE' (A Pilot Trial)

Status:
Active, not recruiting
Trial end date:
2023-03-21
Target enrollment:
Participant gender:
Summary
This study is being conducted to carefully study how chemotherapy is tolerated in group of patients age 70.
Phase:
Phase 1
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborator:
Mayo Clinic
Treatments:
Albumin-Bound Paclitaxel
Carboplatin
Cyclophosphamide
Paclitaxel